Tag
The article examines growing skepticism about the scientific validity of blue zones, the longevity hotspots popularized by Dan Buettner, as researchers question the data and commercialization of the concept.
A critical analysis of Google DeepMind CEO Demis Hassabis's claim at Google I/O that AI could 'solve all diseases,' contextualizing the potential of tools like AlphaFold and AlphaGenome while highlighting the gap between scientific promise and public perception.
Ned Rozell, a longtime science writer for the Alaska Science Forum, retired after 31 years, receiving awards including the Edith Bullock Prize and emeritus status for his contributions to science communication.